Follow-on offering Announced

Silexion Therapeutics Corp equity raising

US$2.5m raised

NASDAQ: SLXN · US$0.65 cash per share

Advisers

Silexion Therapeutics Corp

Issuer

Legal adviser

Lead managers

Placement agent
Issuer
Silexion Therapeutics Corp
Issuer based in
Israel
Sector
Biotech
Tags
Biotech, Oncology, Drug Development

Similar deals

All biotech deals →

Sources

Suggest a correction

A missing adviser, a wrong role or a different outcome. A link to a public source helps.